# OnCo record catnon (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/catnon/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "catnon", "NCT00626990" ;
  schema:name "CATNON (EORTC 26053-22054)"@en ;
  schema:description "CATNON showed that a year of temozolomide after radiotherapy lengthens survival in anaplastic gliomas that lack the 1p/19q co-deletion, and that the benefit is concentrated in IDH-mutant tumours."@en ;
  schema:url <https://onco.cc/trials/catnon/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00626990>, <https://doi.org/10.1016/S0140-6736(17)31442-3> ;
  onco:status "positive" ;
  onco:tag "radiation-wave2" ;
  onco:phase "3" ;
  schema:startDate "2007-12" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/idh-mutant-astrocytoma/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/> ;
  onco:companies <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/> .